260 related articles for article (PubMed ID: 25855877)
1. Noninvasive methods, including transient elastography, for the detection of liver disease in adults with cystic fibrosis.
Sadler MD; Crotty P; Fatovich L; Wilson S; Rabin HR; Myers RP
Can J Gastroenterol Hepatol; 2015 Apr; 29(3):139-44. PubMed ID: 25855877
[TBL] [Abstract][Full Text] [Related]
2. Utility of transient elastography in the non-invasive evaluation of cystic fibrosis liver disease.
Kitson MT; Kemp WW; Iser DM; Paul E; Wilson JW; Roberts SK
Liver Int; 2013 May; 33(5):698-705. PubMed ID: 23432782
[TBL] [Abstract][Full Text] [Related]
3. Supersonic shear-wave elastography and APRI for the detection and staging of liver disease in pediatric cystic fibrosis.
Calvopina DA; Noble C; Weis A; Hartel GF; Ramm LE; Balouch F; Fernandez-Rojo MA; Coleman MA; Lewindon PJ; Ramm GA
J Cyst Fibros; 2020 May; 19(3):449-454. PubMed ID: 31303380
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of Transient Elastography Data Combined With APRI in Detection and Staging of Liver Disease in Pediatric Patients With Cystic Fibrosis.
Lewindon PJ; Puertolas-Lopez MV; Ramm LE; Noble C; Pereira TN; Wixey JA; Hartel GF; Calvopina DA; Leung DH; Ramm GA
Clin Gastroenterol Hepatol; 2019 Nov; 17(12):2561-2569.e5. PubMed ID: 30880274
[TBL] [Abstract][Full Text] [Related]
5. Correlation of Transient Elastography With Severity of Cystic Fibrosis-related Liver Disease.
Aqul A; Jonas MM; Harney S; Raza R; Sawicki GS; Mitchell PD; Fawaz R
J Pediatr Gastroenterol Nutr; 2017 Apr; 64(4):505-511. PubMed ID: 27782957
[TBL] [Abstract][Full Text] [Related]
6. Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease.
Leung DH; Khan M; Minard CG; Guffey D; Ramm LE; Clouston AD; Miller G; Lewindon PJ; Shepherd RW; Ramm GA
Hepatology; 2015 Nov; 62(5):1576-83. PubMed ID: 26223427
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of noninvasive markers for the diagnosis of cystic fibrosis liver disease.
Alexopoulou A; Pouriki S; Vasilieva L; Alexopoulos T; Filaditaki V; Gioka M; Diamantea F; Dourakis SP
Scand J Gastroenterol; 2018 Dec; 53(12):1547-1552. PubMed ID: 30600723
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA Sequencing Identifies a Serum MicroRNA Panel, Which Combined With Aspartate Aminotransferase to Platelet Ratio Index Can Detect and Monitor Liver Disease in Pediatric Cystic Fibrosis.
Calvopina DA; Chatfield MD; Weis A; Coleman MA; Fernandez-Rojo MA; Noble C; Ramm LE; Leung DH; Lewindon PJ; Ramm GA
Hepatology; 2018 Dec; 68(6):2301-2316. PubMed ID: 30014495
[TBL] [Abstract][Full Text] [Related]
9. [Correlation of liver stiffness measured by FibroTouch and FibroScan with Ishak fibrosis score in patients with chronic hepatitis B].
Chen GF; Ping J; Gu HT; Zhao ZM; Zhou Y; Xing F; Tao YY; Mu YP; Liu P; Liu CH
Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):145-150. PubMed ID: 28297803
[No Abstract] [Full Text] [Related]
10. Non-invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scores.
Karlas T; Neuschulz M; Oltmanns A; Güttler A; Petroff D; Wirtz H; Mainz JG; Mössner J; Berg T; Tröltzsch M; Keim V; Wiegand J
PLoS One; 2012; 7(7):e42139. PubMed ID: 22848732
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of transient elastography by FibroScan for the evaluation of liver fibrosis.
Sharma P; Dhawan S; Bansal R; Tyagi P; Bansal N; Singla V; Kumar A; Matin A; Arora A
Indian J Gastroenterol; 2014 Sep; 33(5):445-51. PubMed ID: 25138787
[TBL] [Abstract][Full Text] [Related]
12. Adult-onset cystic fibrosis liver disease: Diagnosis and characterization of an underappreciated entity.
Koh C; Sakiani S; Surana P; Zhao X; Eccleston J; Kleiner DE; Herion D; Liang TJ; Hoofnagle JH; Chernick M; Heller T
Hepatology; 2017 Aug; 66(2):591-601. PubMed ID: 28422310
[TBL] [Abstract][Full Text] [Related]
13. Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: Results from a prospective longitudinal cohort study.
Klotter V; Gunchick C; Siemers E; Rath T; Hudel H; Naehrlich L; Roderfeld M; Roeb E
PLoS One; 2017; 12(6):e0178784. PubMed ID: 28575039
[TBL] [Abstract][Full Text] [Related]
14. A longitudinal assessment of non-invasive biomarkers to diagnose and predict cystic fibrosis-associated liver disease.
Karnsakul W; Wasuwanich P; Ingviya T; Vasilescu A; Carson KA; Mogayzel PJ; Schwarz KB
J Cyst Fibros; 2020 Jul; 19(4):546-552. PubMed ID: 32482593
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Transient Elastography, ShearWave Elastography, Magnetic Resonance Elastography and FibroTest as routine diagnostic markers for assessing liver fibrosis in children with Cystic Fibrosis.
Dana J; Girard M; Franchi-Abella S; Berteloot L; Benoit-Cherifi M; Imbert-Bismut F; Sermet-Gaudelus I; Debray D
Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101855. PubMed ID: 34933150
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver disease.
Witters P; De Boeck K; Dupont L; Proesmans M; Vermeulen F; Servaes R; Verslype C; Laleman W; Nevens F; Hoffman I; Cassiman D
J Cyst Fibros; 2009 Dec; 8(6):392-9. PubMed ID: 19733131
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Liver Disease Progression in Cystic Fibrosis Using Transient Elastography.
Gominon AL; Frison E; Hiriart JB; Vergniol J; Clouzeau H; Enaud R; Bui S; Fayon M; de Ledinghen V; Lamireau T
J Pediatr Gastroenterol Nutr; 2018 Mar; 66(3):455-460. PubMed ID: 29112089
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal Transient Elastography Measurements Used in Follow-up for Patients with Cystic Fibrosis.
Van Biervliet S; Verdievel H; Vande Velde S; De Bruyne R; De Looze D; Verhelst X; Geerts A; Robberecht E; Van Vlierberghe H
Ultrasound Med Biol; 2016 Apr; 42(4):848-54. PubMed ID: 26806442
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of transient elastography (FibroScan) versus the aspartate transaminase to platelet ratio index in assessing liver fibrosis in chronic hepatitis B: the role in primary care setting.
Lesmana CR; Salim S; Hasan I; Sulaiman AS; Gani RA; Pakasi LS; Lesmana LA; Krisnuhoni E; Budihusodo U
J Clin Pathol; 2011 Oct; 64(10):916-20. PubMed ID: 21670074
[TBL] [Abstract][Full Text] [Related]
20. Controlled attenuation parameter: A measure of hepatic steatosis in patients with cystic fibrosis.
Bader RM; Jonas MM; Mitchell PD; Wiggins S; Lee CK
J Cyst Fibros; 2019 Mar; 18(2):280-285. PubMed ID: 30509601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
